Clincosm LogoSign in Get a demo

HYPERTENSION PATIENTS ON DRUG MEDICATION ADHERENCE AND RATIONAL MEDICATION USE

Sponsor
T.C. ORDU ÜNİVERSİTESİ (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05060575
Collaborator
(none)
84
Enrollment
1
Location
2
Arms
8
Anticipated Duration (Months)
10.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This research will be conducted to determine the effects of education and telephone counseling given to hypertension patients on drug treatment compliance and rational drug use.

Research Hypotheses H0: Education and telephone counseling given to hypertension patients do not affect drug treatment compliance.

H1: Education and telephone counseling given to hypertension patients increase drug treatment compliance.

H0: Education and telephone counseling given to hypertension patients do not affect rational drug use.

H1: Education and telephone counseling given to hypertension patients increase rational drug use.

This study was planned as a single-blind randomized controlled experimental study.

Condition or Disease Intervention/Treatment Phase
  • Other: Education and Telephone Counceling
 N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
84 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
THE EFFECT OF EDUCATION AND TELEPHONE COUNSELING GIVEN TO HYPERTENSION PATIENTS ON DRUG MEDICATION ADHERENCE AND RATIONAL MEDICATION USE: SINGLE-BLIND RANDOMIZED CONTROLLED TRIAL
Anticipated Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
May 1, 2022
Anticipated Study Completion Date :
Jun 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: EDUTC

Drug use and rational drug use training will be given to hypertension patients in the experimental group. The patients in the experimental group twice in the 1st month (2nd and 4th weeks), once in the 2nd month (8th week) and once in the 3rd month (12th week) phone call counseling will be providedved an average of 10-15 minutes.

Other: Education and Telephone Counceling
Drug use and rational drug use training will be given to hypertension patients in the experimental group. The patients in the experimental group twice in the 1st month (2nd and 4th weeks), once in the 2nd month (8th week) and once in the 3rd month (12th week) phone call counseling will be providedved an average of 10-15 minutes.
Active Comparator: Control Group

Routine hospital care.

Other: Education and Telephone Counceling
Drug use and rational drug use training will be given to hypertension patients in the experimental group. The patients in the experimental group twice in the 1st month (2nd and 4th weeks), once in the 2nd month (8th week) and once in the 3rd month (12th week) phone call counseling will be providedved an average of 10-15 minutes.

Outcome Measures

Primary Outcome Measures

  1. Adherence to Medication Self-Efficacy Scale [12 weeks]

    The scale consists of 13 items and determines the self-efficacy/confidence level of adherence to drug treatments of individuals with hypertension. The scale is evaluated by scoring from 1 to 4 in each question. The minimum score that can be obtained from the scale is 13, and the maximum score is 52. The increase in the scale score indicates that the compliance of individuals to antihypertensive drug treatment increases positively.

  2. Rational Drug Use Scale [12 weeks]

    The scale has 36 items and is a triple Likert type. Behavioral beliefs (items 1-9), Control beliefs (items 10-16), Attitude (items 17-21), Subjective norm (items 22-23), Intention (items 24-28), and Knowledge It has 6 sub-dimensions (items between 29 and 36). Scoring of scale items was never (0), sometimes (1), and always (2) for positive items; negative items (items 13, 14, 17, 18, 19, 20, 21, and 24) are calculated as never (2), sometimes (1), and always (0). The scores that can be obtained from the scale range from 0 to 72. As the score obtained from the scale increases, the level of rational drug use increases.

Secondary Outcome Measures

  1. Diastolic/Systolic blood pressure [12 weeks]

    Systolic and Diastolic blood pressure will be measured.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
    • Diagnosed with hypertension,

  • Hypertension disease duration of at least 6 months,

  • Using at least one drug due to hypertension,

  • 18 years old and over

  • Literate,

  • Living in the town centre,

  • Owns a phone

  • Open to communication and cooperation,

  • Patients willing to participate in the study will be included in the study.

Exclusion Criteria:

  • Having a psychiatric illness

  • Hearing loss,

  • Can't understand or speak Turkish and

  • Patients who do not wish to continue the study will be excluded from the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hacer GÖK UĞUR Ordu Cumhuriyet Campus Cumhuriyet District Turkey 52200

Sponsors and Collaborators

  • T.C. ORDU ÜNİVERSİTESİ

Investigators

  • Principal Investigator: Hacer GÖK UĞUR, Assoc., Ordu Ünivercity

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hacer Gok Ugur, Associate Professor, T.C. ORDU ÜNİVERSİTESİ
ClinicalTrials.gov Identifier:
NCT05060575
Other Study ID Numbers:
  • ayyuzlum3207
First Posted:
Sep 29, 2021
Last Update Posted:
Sep 29, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hacer Gok Ugur, Associate Professor, T.C. ORDU ÜNİVERSİTESİ
1- Hypertension 2-Tele nursing 3-Education 4-Rational medication use 5-Drug medication adherence,6-Nursing
Additional relevant MeSH terms:
Hypertension

Study Results

No Results Posted as of Sep 29, 2021